PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 71.10
+4.20 (6.28%)
Oct 31, 2025, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 10.22 billion as of October 31, 2025. Its market cap has decreased by -19.84% in one year.
Market Cap
10.22B
Enterprise Value
4.82B
Revenue
2.48B
Ranking
n/a
PE Ratio
6.28
Stock Price
71.10
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 10.22B, an increase of 89.93%. That is a compound annual growth rate of 4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 10.22B | -21.26% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | 8.43B | -15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 181.96B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lotus Pharmaceutical | 75.87B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.27B |
| Polaris Group | 27.16B |
| Pegavision | 25.74B |